Additional Reading & Resources
Additional resources for patient-centered material
Triple-Negative Breast Cancer
American Cancer Society. Triple-negative Breast Cancer. Updated September 20, 2019. Accessed August 11, 2020. https://www.cancer.org/cancer/breast-cancer/understanding-a-breast-cancer-diagnosis/types-of-breast-cancer/triple-negative.html
CancerCare. Triple Negative Breast Cancer. Accessed August 11, 2020. https://www.cancercare.org/diagnosis/triple_negative_breast_cancer
Centers for Disease Control and Prevention (CDC). Triple-Negative Breast Cancer. Updated July 26, 2019. Accessed August 11, 2020. https://www.cdc.gov/cancer/breast/triple-negative.htm
National Comprehensive Cancer Network (NCCN). NCCN Guidelines for Patients: Metastatic Breast Cancer, 2020. Accessed August 11, 2020. https://www.nccn.org/patients/guidelines/content/PDF/stage_iv_breast-patient.pdf
HR+ HER2- Breast Cancer
Living Beyond Breast Cancer. Diagnosed With Hormone Receptor-Positive Breast Cancer. Accessed August 11, 2020. https://www.lbbc.org/diagnosed-hormone-receptor-positive-breast-cancer
MedlinePlus. HER2 (Breast Cancer) Testing. Updated July 31, 2020. Accessed August 11, 2020. https://medlineplus.gov/lab-tests/her2-breast-cancer-testing/
NIH. National Cancer Institute. Breast Cancer Treatment (Adult) (PDQ®)–Patient Version. Updated November 21, 2019. Accessed August 11, 2020. https://www.cancer.gov/types/breast/patient/breast-treatment-pdq#_148
National Comprehensive Cancer Network (NCCN). NCCN Guidelines for Patients: Metastatic Breast Cancer, 2020. Accessed August 11, 2020. https://www.nccn.org/patients/guidelines/content/PDF/stage_iv_breast-patient.pdf
HER2+ Breast Cancer
American Cancer Society. Breast Cancer HER2 Status. Updated September 20, 2019. Accessed August 11, 2020. https://www.cancer.org/cancer/breast-cancer/understanding-a-breast-cancer-diagnosis/breast-cancer-her2-status.html
Mayo Clinic. HER2-postive breast cancer: What is it? Published April 07, 2020. Accessed August 11, 2020. https://www.mayoclinic.org/breast-cancer/expert-answers/faq-20058066
National Comprehensive Cancer Network (NCCN). NCCN Guidelines for Patients: Metastatic Breast Cancer, 2020. Accessed August 11, 2020. https://www.nccn.org/patients/guidelines/content/PDF/stage_iv_breast-patient.pdf
Immune-related Adverse Events
NCCN. Immunotherapy side effects. Accessed August 26, 2020. https://www.nccn.org/patients/guidelines/content/PDF/immunotherapy-se-ici-patient.pdf
Oncology Nursing Society. Immunotherapy wallet card, 2018. Accessed August 26, 2020. https://www.nccn.org/patients/guidelines/content/PDF/stage_iv_breast-patient.pdf
American Cancer Society. Managing Cancer-related Side Effects. Accessed August 11, 2020. https://www.cancer.org/treatment/treatments-and-side-effects/physical-side-effects.html
BreastCancer.ORG. Managing Chemotherapy Side Effects. Updated March 25, 2020. Accessed August 11, 2020. https://www.breastcancer.org/treatment/chemotherapy/side_effects
National Comprehensive Cancer Network (NCCN). NCCN Guidelines for Patients: Metastatic Breast Cancer, 2020. Accessed August 11, 2020. https://www.nccn.org/patients/guidelines/content/PDF/stage_iv_breast-patient.pdf
Additional resources for health professional-centered material
Triple-Negative Breast Cancer
Mayo Clinic. Clinical Trials: Triple Negative Breast Cancer. Accessed August 11, 2020. https://www.mayo.edu/research/clinical-trials/diseases-conditions/triple-negative-breast-cancer
National Cancer Institute. Breast Cancer Treatment (Adult) (PDQ®)–Health Professional Version. Updated July 22, 2020. Accessed August 11, 2020. https://www.cancer.gov/types/breast/hp/breast-treatment-pdq
National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Breast Cancer: v5.2020. Published July 15, 2020. Accessed August 11, 2020. https://www.nccn.org/professionals/physician_gls/pdf/breast.pdf
HR+ HER2- Breast Cancer
Cancer.Net. Treatment of Advanced HER2-Negative Breast Cancer. Published September 2, 2014. Accessed August 11, 2020. https://www.cancer.net/research-and-advocacy/asco-care-and-treatment-recommendations-patients/treatment-advanced-her2-negative-breast-cancer
NIH. National Cancer Institute. Cancer Stat Facts: Female Breast Cancer Subtypes. Accessed August 11, 2020. https://seer.cancer.gov/statfacts/html/breast-subtypes.html
National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Breast Cancer: v5.2020. Published July 15, 2020. Accessed August 11, 2020. https://www.nccn.org/professionals/physician_gls/pdf/breast.pdf
HER2+ Breast Cancer
Clinical Care Options: Oncology. HER2-Positive Breast Cancer: New Findings, Expanded Options, and an Evolving Treatment Paradigm. Accessed August 11, 2020. https://www.clinicaloptions.com/oncology/programs/her2-breast-cancer-updates
Living Beyond Breast Cancer. Healthcare Provider Resources. Accessed August 11, 2020. https://www.lbbc.org/healthcare-provider/healthcare-provider-resources
NIH. National Cancer Institute. For Metastatic HER2-Positive Breast Cancer, New Treatments Emerge. Published January 8, 2020. Accessed August 11, 2020. https://www.cancer.gov/news-events/cancer-currents-blog/2020/tucatinib-trastuzumab-deruxtecan-her2-positive-metastatic-breast-cancer
National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Breast Cancer: v5.2020. Published July 15, 2020. Accessed August 11, 2020. https://www.nccn.org/professionals/physician_gls/pdf/breast.pdf
Immune-related Adverse Events
Wood LS, et al. Immune checkpoint inhibitor therapy: Key principles when educating patients. CJON. 2019;23:271-280. Accessed August 26, 2020.
https://cjon.ons.org/cjon/23/3/immune-checkpoint-inhibitor-therapy-key-principles-when-educating-patients
Johnson JB, et al. Immune checkpoint inhibitor toxicities: systems-based approaches to improve patient care and research. Lancet Oncol. 2020;21:E398-E404. Accessed August 26, 2020.
https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(20)30107-8/fulltext
Brahmer JR, et al. Management of immune-related adverse events in patients treated with immune checkpoint inhibitor therapy: American Society of Clinical Oncology Practice Guideline. J Clin Oncol. 2018;36:1714-1768. Accessed August 26, 2020.
https://ascopubs.org/doi/abs/10.1200/JCO.2017.77.6385
ONS Voice. Using CTCAE to report immunotherapy adverse events, 2018. Accessed August 26, 2020.
https://voice.ons.org/news-and-views/using-ctcae-to-report-immunotherapy-adverse-events
Breast Cancer: Immune-related Adverse Events
American Cancer Society. Managing Cancer-related Side Effects. Accessed August 11, 2020.
https://www.cancer.org/treatment/treatments-and-side-effects/physical-side-effects.html
BreastCancer.ORG. Managing Chemotherapy Side Effects. Updated March 25, 2020. Accessed August 11, 2020.
https://www.breastcancer.org/treatment/chemotherapy/side_effects
National Comprehensive Cancer Network (NCCN). NCCN Guidelines for Patients: Metastatic Breast Cancer, 2020. Accessed August 11, 2020.
https://www.nccn.org/patients/guidelines/content/PDF/stage_iv_breast-patient.pdf